368 related articles for article (PubMed ID: 12873579)
1. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
Fille M; Larcher C; Dierich MP; Allerberger F
Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
[TBL] [Abstract][Full Text] [Related]
5. Lack of value of repeat stool testing for Clostridium difficile toxin.
Mohan SS; McDermott BP; Parchuri S; Cunha BA
Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
[TBL] [Abstract][Full Text] [Related]
6. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
8. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
Chan EL; Seales D; Drum H
Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
[TBL] [Abstract][Full Text] [Related]
9. [Six years evaluation of Clostridium difficile associated diarrhea].
Ercis S; Ergin A; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
[TBL] [Abstract][Full Text] [Related]
10. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
Snell H; Ramos M; Longo S; John M; Hussain Z
J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
[TBL] [Abstract][Full Text] [Related]
11. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
Sednaoui P; el Mantih B; Cauwell M
Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a commercial latex agglutination assay for screening for Clostridium difficile-associated disease.
Stella PA
Clin Lab Sci; 1994; 7(5):311-3. PubMed ID: 10150387
[TBL] [Abstract][Full Text] [Related]
17. Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease.
Markowitz JE; Brown KA; Mamula P; Drott HR; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2001 Sep; 96(9):2688-90. PubMed ID: 11569696
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and diagnosis of clostridium difficile enterocolitis.
Möllby R; Aronsson B; Nord CE
Scand J Infect Dis Suppl; 1985; 46():47-56. PubMed ID: 3906856
[TBL] [Abstract][Full Text] [Related]
19. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
